Fuller & Thaler Asset Management
CDLX icon

Fuller & Thaler Asset Management’s Cardlytics CDLX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,161
Closed -$2.63M – 568
2024
Q1 		$2.63M Buy
+18,161
New +$1.53M 0.01% 348
2020
Q1 		– Sell
-6,896
Closed -$4.33M – 486
2019
Q4 		$4.33M Sell
6,896
-916
-12% -$448K 0.05% 227
2019
Q3 		$2.62M Sell
7,812
-3,976
-34% -$1.27M 0.03% 257
2019
Q2 		$3.06M Sell
11,788
-60
-0.5% -$12K 0.04% 240
2019
Q1 		$1.96M Buy
+11,848
New +$1.93M 0.02% 282

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management's CDLX Position: Q2 2024 in Review

Fuller & Thaler Asset Management sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 18,161 shares — an estimated $2.63M sold.

Fuller & Thaler Asset Management first reported a position in CDLX in Q1 2019 and held it in 5 quarters. The position peaked at $4.33M in Q4 2019. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Fuller & Thaler Asset Management reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 18,161 Cardlytics shares in Q2 2024, an estimated $2.63M.
  • Fuller & Thaler Asset Management first reported a position in Cardlytics in Q1 2019 and held it in 5 quarters.
  • Fuller & Thaler Asset Management's Cardlytics position peaked at $4.33M in Q4 2019.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.